News

2018-11-21

PRESS RELEASE: Ascelia Pharma receives positive feedback from FDA on design of the pivotal Phase 3 study with Mangoral®

Read more
2018-11-13

PRESS RELEASE: Encouraging results from clinical Phase I study of Oncoral presented in a new publication

Read more
2018-10-23

PRESS RELEASE: Oncoral demonstrates encouraging results in clinical phase I

Read more
2018-09-14

PRESS RELEASE: Carl Bjartmar appointed as new Chief Medical Officer for Ascelia Pharma

Read more
2018-09-10

PRESS RELEASE: Oncoral phase 1 results to be presented at ESMO congress in Munich

Read more
2018-06-13

PRESS RELEASE: Patent for Oncoral has been approved in the US

Read more
2018-05-16

PRESS RELEASE: Ascelia Pharma has raised SEK 60 million to finalize phase III preparations for Mangoral®

Read more
2017-11-13

PRESS RELEASE: Ascelia Pharma strengthens its board of directors to support international expansion

Read more
2017-10-30

PRESS RELEASE: Ascelia Pharma strengthens its oncology product portfolio

Read more